W. Bryan Hubbard - The Ibogaine Initiative: Solutions for Opioid Addiction & Brain Injury
Release Date: 05/26/2025
The Psychedelic Podcast
In this episode of The Psychedelic Podcast, host Paul F. Austin welcomes cultural historian and acclaimed author Mike Jay. Find full show notes and links here: Together they explore the untold history of nitrous oxide, psychedelic experimentation in the Romantic era, and the deeper cultural and philosophical roots of psychedelic science. Mike shares insights from his latest book, Free Radicals, highlighting how figures like Humphry Davy and William James helped shape psychedelic thought long before the 1960s. The conversation weaves through ancient San Pedro rituals, colonial attempts to...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, host Paul F. Austin welcomes Brian Robertson—creator of Holacracy and founder of Ledgeway Sangha—for a thought-provoking conversation at the intersection of organizational design, spiritual community, and psychedelic practice. Find full show notes and links here: Best known for reimagining how companies structure authority through Holacracy, Brian now brings his systems-level insight into the realm of psychedelic spirituality. He shares the origin and mission of Ledgeway Sangha, a legal psychedelic church rooted in peer-to-peer healing, communal...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Dr. Vass Eliopoulos, co-founder of Longevity Health and a pioneer at the intersection of regenerative medicine, longevity science, and psychedelics. Find full show notes and links here: Dr. Vass shares his journey from emergency medicine to a proactive, prevention-based approach to health optimization for high performers. Dr. Vass shares why today’s healthcare system fails to address the root causes of disease, the synergistic potential of psychedelics, stem cells, peptides, and hyperbaric oxygen therapy, and how chronic...
info_outlineThe Psychedelic Podcast
Following our recent conversation with Dr. Robin Carhart-Harris on the neuroscience of SSRIs and psychedelics, this bonus episode takes the next step—focusing on clinical realities, tapering strategies, and patient safety. Find full show notes and links here: Dr. Dave Rabin—a board-certified psychiatrist, neuroscientist, and co-founder of Apollo Neuro—joins Paul F. Austin for a candid, protocol-driven conversation. Together, they unpack why combining SSRIs with psychedelics can be dangerous, how to safely taper with support tools like ketamine and CBDA, and how to prepare clients...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Dr. Dan Engle—psychiatrist, neurologist, and integrative medicine pioneer—for a profound discussion on psychedelics, brain health, and healing. Find full show notes and links here: Dr. Dan shares his personal journey through traumatic brain injuries and recovery through both Western neurology and indigenous plant medicine traditions. They explore neuroplasticity vs. neurogenesis, ibogaine’s potential in brain injury recovery, and how belief, awe, and prayer shape healing outcomes. Dr. Dan also reflects on lessons...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin is joined by renowned neuroscientist Dr. Robin Carhart-Harris and microdosing policy advocate John Downs for a replay of a live event originally held on June 10th, Microdosing vs. SSRIs: What’s Happening in the Brain and Why It Matters. Find full show notes and links here: Together, they explore the scientific distinctions between SSRIs and psychedelics, focusing on neuroimaging, brain entropy, emotional processing, and the REBUS model. Dr. Carhart-Harris shares key insights from landmark studies on psilocybin therapy and...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, host Paul F. Austin welcomes back J. Ashley T. Booth, LCSW, MS—a longtime friend, therapist, and psychedelic pioneer. Find full show notes and links here: Ashley shares her journey from community activism to clinical work with ketamine and MDMA, and her new illustrated guide to IFS, Quieting the Storm Within. J. Ashley T. Booth, LCSW, MS has led the Southern California Psychedelic Society, served as MAPS trial coordinator for MDMA-assisted PTSD therapy, co-founded a ketamine clinic, and offers IFS, Hakomi, integration, and harm reduction...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes anthropologist and author Dr. Manvir Singh to explore the enduring power of shamanism as a psychological and cultural technology. Find full show notes and links here: Singh discusses insights from his fieldwork with the Mentawai people and Amazonian Yopo shamans, explaining how ritual, performance, and belief help people manage uncertainty and catalyze healing. Together with Paul, he examines the contested history of ancient psychedelic use, the risks of neo-shamanic narratives, and the deep psychological roots of sacred...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with Natalie Baird-King, a board-certified attorney in marital and family law who discovered the transformative power of forgiveness through psychedelic experiences. Find full show notes and links here: Natalie shares her journey from childhood abuse and depression to spiritual healing catalyzed by ayahuasca. As the author of Forgiving Unforgivable, she explains her HOPE model (Harken back, Open your heart, Proclaim forgiveness, Experience freedom) and how forgiveness—particularly self-forgiveness—became the key to healing...
info_outlineThe Psychedelic Podcast
In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Rachel Pastor and Tiffany Hurd, leaders behind , a woman-led microdosing company pushing the boundaries of accessibility, education, and intention in the psychedelic space. Find full show notes and links here: From overcoming heroin addiction and corporate burnout to leading a values-driven microdosing brand, Rachel and Tiffany share their powerful personal journeys and the mission that fuels their work today. They dive into the evolving landscape of legal psychedelics, the challenges of running a public-facing...
info_outlineIn this episode of The Psychedelic Podcast, Paul F. Austin welcomes Bryan Hubbard, a prominent advocate for psychedelic-assisted therapies, particularly ibogaine in the treatment of opioid addiction and mental health disorders.
Find full show notes and links here: https://thethirdwave.co/podcast/episode-305/?ref=278
Update (May 2025): Days before this episode's release, the Texas House approved a Senate-backed bill to fund ibogaine research through a public-private partnership aimed at securing FDA approval. This vote marks a major milestone in the movement Bryan describes throughout this conversation.
Bryan shares his journey from leading Kentucky's Opioid Abatement Advisory Commission to spearheading breakthrough ibogaine research initiatives in Texas. He articulates ibogaine's unique neurological properties, discussing how it can reset brain neurochemistry in 36 hours and potentially treat conditions from traumatic brain injury to Parkinson's disease. The conversation explores the spiritual dimensions of ibogaine experiences, the political landscape surrounding psychedelic medicine, and Bryan's ongoing efforts to medicalize ibogaine through FDA drug development trials, highlighting Texas as the next frontier for this life-saving research.
W. Bryan Hubbard is the Executive Director of the American Ibogaine Initiative. He is the first and former Chairman and Executive Director of the Kentucky Opioid Abatement Advisory Commission. He concurrently served as Special Counsel to the Kentucky Attorney General’s Office of Medicaid Fraud and Abuse Control and was its prior Executive Director. He served on the Kentucky Judicial Commission on Mental Health, the Kentucky Child Support Guidelines Commission, Mine Safety Review Board, and the Kentucky Office of Drug Control Policy’s Recovery Ready Communities Advisory Council. He previously served as Commissioner of the Kentucky Department of Income Support wherein he led the Commonwealth’s Social Security Disability and Child Support Enforcement systems. He practiced workers’ compensation law representing Walmart, Tyson Foods, and Tennessee Valley Authority for sixteen years. During his practice years, he observed the predacious onset of Kentucky’s Opioid Epidemic amid generational joblessness, poverty, disability, and substance use. He was raised in Virginia’s coalfields and is the proud grandson of two grade-school educated coal miners on whose shoulders he stands.
Highlights:
- Why ibogaine interrupts addiction instantly
- The Stanford study that changed everything
- Resetting brain neurochemistry in 36 hours
- From Parkinson's to PTSD: Ibogaine's broad applications
- The spiritual awakening dimension of treatment
- How pharmaceutical interests block breakthrough medicine
- Kentucky's lost opportunity: $42 million for research
- Texas as the new frontier for ibogaine medicalization
- Matrix pharmacology: Ibogaine's intelligent mechanism
- The political war over life-saving psychedelic medicine
Episode Links
- Website
- American Ibogaine Initiative
- Instagram: @w_bryan_hubbard
- X (Formerly Twitter): @w_bryan_hubbard
Episode Sponsors:
- Golden Rule Mushrooms - Get a lifetime discount of 10% with code THIRDWAVE at checkout